InsidersTradesSigma
国药现代 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 国药现代 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 国药现代 has published 3 public disclosures. Market capitalisation: €13.5bn. The latest transaction was filed on 12 April 2023 (Purchase). Among the most active insiders: 李显林. Every trade is openly available.
3
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,410 of 25,577 companies
74.3
score / 100
Value84
Quality65
FCF yld12%
Earn yld7.8%
EV/EBITDA5.9x
ROE5.7%
Gross mgn32%
Net mgn10%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 April 2023
Declarations3 total
3 of 3 declarations